HASAN M QUTOB MD
Prescription History 1285793521
Internal Medicine - Endocrinology, Diabetes & Metabolism in Michigan City, IN
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for HASAN M QUTOB MD, an active Endocrinology, Diabetes & Metabolism specialist practicing in Michigan City, IN. Our medical registry currently tracks 114 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 13,539 documented patient claims. Among these therapy options, the most frequently utilized medication is Glimepiride, which accounts for 1,115 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other IN PrescribersVs. IN Avg |
|---|---|---|---|
| Glimepiride | 1,115 | $23.58 | ▲ More than typical |
About Glimepiride: Glimepiride is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glimepiride belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. Alkaloids derived from TYRAMINE combined with 3,4-dihydroxybenzaldehyde via a norbelladine pathway, including GALANTAMINE, lycorine and crinine. They are found in the AMARYLLIDACEAE plant family. In 2023, this provider wrote 1,115 Medicare prescriptions for Glimepiride, about 21 times the volume of the typical Indiana prescriber of this medication (52). Medicare paid an average of $23.58 per fill, versus $10.74 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 2,908.9 30-Day Fills standardized to 30-day supplies 86,596 Days of Medication total across all patients in 2023 | |||
| Metformin Hcl | 818 | $14.01 | ▲ More than typical |
About Metformin Hcl: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2023, this provider wrote 818 Medicare prescriptions for Metformin Hcl, about 8.1 times the volume of the typical Indiana prescriber of this medication (101). Medicare paid an average of $14.01 per fill, versus $7.70 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 2,129.7 30-Day Fills standardized to 30-day supplies 63,526 Days of Medication total across all patients in 2023 | |||
| JardianceEmpagliflozin | 815 | $1,064.40 | ▲ More than typical |
About Jardiance: Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Empagliflozin works by increasing the removal of sodium by your kidneys. In 2023, this provider wrote 815 Medicare prescriptions for Jardiance, about 19 times the volume of the typical Indiana prescriber of this medication (44). Medicare paid an average of $1,064.40 per fill, versus $1,037.17 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 1,475.6 30-Day Fills standardized to 30-day supplies 44,111 Days of Medication total across all patients in 2023 | |||
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 814 | $896.69 | ▲ More than typical |
About Lantus Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 814 Medicare prescriptions for Lantus Solostar, about 19 times the volume of the typical Indiana prescriber of this medication (42). Medicare paid an average of $896.69 per fill, versus $706.78 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 1,649.8 30-Day Fills standardized to 30-day supplies 48,981 Days of Medication total across all patients in 2023 | |||
| Metformin Hcl ErMetformin Hcl | 810 | $20.29 | ▲ More than typical |
About Metformin Hcl Er: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2023, this provider wrote 810 Medicare prescriptions for Metformin Hcl Er, about 14 times the volume of the typical Indiana prescriber of this medication (58). Medicare paid an average of $20.29 per fill, versus $10.14 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 2,060.4 30-Day Fills standardized to 30-day supplies 61,617 Days of Medication total across all patients in 2023 | |||
| OzempicSemaglutide | 763 | $1,713.31 | ▲ More than typical |
About Ozempic: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment. In 2023, this provider wrote 763 Medicare prescriptions for Ozempic, about 20 times the volume of the typical Indiana prescriber of this medication (39). Medicare paid an average of $1,713.31 per fill, versus $1,432.50 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 1,351.9 30-Day Fills standardized to 30-day supplies 39,722 Days of Medication total across all patients in 2023 | |||
| FarxigaDapagliflozin Propanediol | 759 | $900.59▼ below IN avg | ▲ More than typical |
About Farxiga: Dapagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used in people with type 2 diabetes and heart disease to lower the risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sugar by your kidneys. Dapagliflozin is also used to treat kidney disease and heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sodium by your kidneys. In 2023, this provider wrote 759 Medicare prescriptions for Farxiga, about 22 times the volume of the typical Indiana prescriber of this medication (34). Medicare paid an average of $900.59 per fill, versus $938.67 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 1,231.1 30-Day Fills standardized to 30-day supplies 36,111 Days of Medication total across all patients in 2023 | |||
| Levothyroxine Sodium | 599 | $16.49 | ▲ More than typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2023, this provider wrote 599 Medicare prescriptions for Levothyroxine Sodium, about 3.7 times the volume of the typical Indiana prescriber of this medication (164). Medicare paid an average of $16.49 per fill, versus $16.04 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 1,428.7 30-Day Fills standardized to 30-day supplies 42,685 Days of Medication total across all patients in 2023 | |||
| Novolog FlexpenInsulin Aspart | 474 | $1,019.03▼ below IN avg | ▲ More than typical |
About Novolog Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2023, this provider wrote 474 Medicare prescriptions for Novolog Flexpen, about 14 times the volume of the typical Indiana prescriber of this medication (35). Medicare paid an average of $1,019.03 per fill, versus $1,053.00 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 921.7 30-Day Fills standardized to 30-day supplies 27,439 Days of Medication total across all patients in 2023 | |||
| TrulicityDulaglutide | 434 | $1,516.61 | ▲ More than typical |
About Trulicity: Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment. In 2023, this provider wrote 434 Medicare prescriptions for Trulicity, about 9.9 times the volume of the typical Indiana prescriber of this medication (44). Medicare paid an average of $1,516.61 per fill, versus $1,381.91 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 668.5 30-Day Fills standardized to 30-day supplies 19,447 Days of Medication total across all patients in 2023 | |||
| JanuviaSitagliptin Phosphate | 366 | $1,128.27 | ▲ More than typical |
About Januvia: Sitagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Sitagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES. In 2023, this provider wrote 366 Medicare prescriptions for Januvia, about 11 times the volume of the typical Indiana prescriber of this medication (32). Medicare paid an average of $1,128.27 per fill, versus $1,035.73 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 760 30-Day Fills standardized to 30-day supplies 22,795 Days of Medication total across all patients in 2023 | |||
| Humalog Kwikpen U-100Insulin Lispro | 288 | $884.89▼ below IN avg | ▲ More than typical |
About Humalog Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2023, this provider wrote 288 Medicare prescriptions for Humalog Kwikpen U-100, about 9.3 times the volume of the typical Indiana prescriber of this medication (31). Medicare paid an average of $884.89 per fill, versus $1,115.77 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 616.6 30-Day Fills standardized to 30-day supplies 18,334 Days of Medication total across all patients in 2023 | |||
| Atorvastatin Calcium | 251 | $18.01 | ≈ Typical |
About Atorvastatin Calcium: Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors. In 2023, this provider wrote 251 Medicare prescriptions for Atorvastatin Calcium, about 1.2 times the volume of the typical Indiana prescriber of this medication (216). Medicare paid an average of $18.01 per fill, versus $11.73 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 723.7 30-Day Fills standardized to 30-day supplies 21,684 Days of Medication total across all patients in 2023 | |||
| LantusInsulin Glargine,hum.Rec.Anlog | 232 | $1,017.52 | ▲ More than typical |
About Lantus: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 232 Medicare prescriptions for Lantus, about 8.6 times the volume of the typical Indiana prescriber of this medication (27). Medicare paid an average of $1,017.52 per fill, versus $602.64 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 411.6 30-Day Fills standardized to 30-day supplies 12,104 Days of Medication total across all patients in 2023 | |||
| Tresiba Flextouch U-100Insulin Degludec | 203 | $739.83▼ below IN avg | ▲ More than typical |
About Tresiba Flextouch U-100: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2023, this provider wrote 203 Medicare prescriptions for Tresiba Flextouch U-100, about 7.8 times the volume of the typical Indiana prescriber of this medication (26). Medicare paid an average of $739.83 per fill, versus $765.23 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 458.7 30-Day Fills standardized to 30-day supplies 13,691 Days of Medication total across all patients in 2023 | |||
| Nateglinide | 203 | $90.26 | ▲ More than typical |
About Nateglinide: Nateglinide is used alone or with other medications to control high blood sugar along with a proper diet and exercise program. Show more ▾ It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. It works by stimulating the body to produce more insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. A phenylalanine and cyclohexane derivative that acts as a hypoglycemic agent by stimulating the release of insulin from the pancreas. It is used in the treatment of TYPE 2 DIABETES. In 2023, this provider wrote 203 Medicare prescriptions for Nateglinide, about 10 times the volume of the typical Indiana prescriber of this medication (20). Medicare paid an average of $90.26 per fill, versus $74.09 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 447.5 30-Day Fills standardized to 30-day supplies 13,346 Days of Medication total across all patients in 2023 | |||
| Lisinopril | 180 | $9.82 | ▲ More than typical |
About Lisinopril: Lisinopril is used to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat heart failure and to improve survival after a heart attack. Lisinopril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily. One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure. In 2023, this provider wrote 180 Medicare prescriptions for Lisinopril, about 1.4 times the volume of the typical Indiana prescriber of this medication (131). Medicare paid an average of $9.82 per fill, versus $6.41 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 511 30-Day Fills standardized to 30-day supplies 15,306 Days of Medication total across all patients in 2023 | |||
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 171 | $99.58 | ▲ More than typical |
In 2023, this provider wrote 171 Medicare prescriptions for Nano 2nd Gen Pen Needle, about 6.3 times the volume of the typical Indiana prescriber of this medication (27). Medicare paid an average of $99.58 per fill, versus $94.75 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 346.8 30-Day Fills standardized to 30-day supplies 10,672 Days of Medication total across all patients in 2023 | |||
| InvokanaCanagliflozin | 170 | $1,187.13 | ▲ More than typical |
About Invokana: Canagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Canagliflozin is also used by people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Canagliflozin is also used by people with type 2 diabetes and kidney disease to lower the risk of dialysis, death from heart disease, and the need to go to the hospital for heart failure. Canagliflozin works by increasing the removal of sugar by your kidneys. A glucoside-derived SODIUM-GLUCOSE TRANSPORTER 2 inhibitor that stimulates urinary excretion of glucose by suppressing renal glucose reabsorption. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2023, this provider wrote 170 Medicare prescriptions for Invokana, about 8.9 times the volume of the typical Indiana prescriber of this medication (19). Medicare paid an average of $1,187.13 per fill, versus $886.44 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 368 30-Day Fills standardized to 30-day supplies 10,967 Days of Medication total across all patients in 2023 | |||
| NovologInsulin Aspart | 156 | $1,305.63 | ▲ More than typical |
About Novolog: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2023, this provider wrote 156 Medicare prescriptions for Novolog, about 5.6 times the volume of the typical Indiana prescriber of this medication (28). Medicare paid an average of $1,305.63 per fill, versus $911.26 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 284.3 30-Day Fills standardized to 30-day supplies 8,472 Days of Medication total across all patients in 2023 | |||
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 152 | $93.12 | ▲ More than typical |
In 2023, this provider wrote 152 Medicare prescriptions for Ultra-Fine Mini Pen Needle, about 6.9 times the volume of the typical Indiana prescriber of this medication (22). Medicare paid an average of $93.12 per fill, versus $88.89 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 304.3 30-Day Fills standardized to 30-day supplies 9,012 Days of Medication total across all patients in 2023 | |||
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 146 | $1,368.55▼ below IN avg | ▲ More than typical |
About Toujeo Max Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 146 Medicare prescriptions for Toujeo Max Solostar, about 5.6 times the volume of the typical Indiana prescriber of this medication (26). Medicare paid an average of $1,368.55 per fill, versus $1,386.59 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 281.8 30-Day Fills standardized to 30-day supplies 8,327 Days of Medication total across all patients in 2023 | |||
| HumalogInsulin Lispro | 145 | $1,153.36 | ▲ More than typical |
About Humalog: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2023, this provider wrote 145 Medicare prescriptions for Humalog, about 4.8 times the volume of the typical Indiana prescriber of this medication (30). Medicare paid an average of $1,153.36 per fill, versus $819.59 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 267.4 30-Day Fills standardized to 30-day supplies 7,948 Days of Medication total across all patients in 2023 | |||
| MounjaroTirzepatide | 137 | $1,850.76 | ▲ More than typical |
About Mounjaro: Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. It lowers blood sugar by causing the release of your body's natural insulin and decreasing the amount of sugar your liver makes. A glucose-dependent insulinotropic polypeptide (GIP) receptor and Glucose-like peptide-1 (GLP-1) receptor agonist to enhance glycemic control in adults with TYPE 2 DIABETES MELLITUS. In 2023, this provider wrote 137 Medicare prescriptions for Mounjaro, about 7.2 times the volume of the typical Indiana prescriber of this medication (19). Medicare paid an average of $1,850.76 per fill, versus $1,183.51 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 234.2 30-Day Fills standardized to 30-day supplies 6,860 Days of Medication total across all patients in 2023 | |||
| Droplet Pen NeedlePen Needle, Diabetic | 120 | $96.55 | ▲ More than typical |
In 2023, this provider wrote 120 Medicare prescriptions for Droplet Pen Needle, about 6.3 times the volume of the typical Indiana prescriber of this medication (19). Medicare paid an average of $96.55 per fill, versus $85.81 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 283.7 30-Day Fills standardized to 30-day supplies 8,456 Days of Medication total across all patients in 2023 | |||
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 119 | $745.97 | ▲ More than typical |
About Basaglar Kwikpen U-100: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 119 Medicare prescriptions for Basaglar Kwikpen U-100, about 4.4 times the volume of the typical Indiana prescriber of this medication (27). Medicare paid an average of $745.97 per fill, versus $444.62 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 192.4 30-Day Fills standardized to 30-day supplies 5,627 Days of Medication total across all patients in 2023 | |||
| Glipizide ErGlipizide | 118 | $28.72 | ▲ More than typical |
About Glipizide Er: Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. An oral hypoglycemic agent which is rapidly absorbed and completely metabolized. In 2023, this provider wrote 118 Medicare prescriptions for Glipizide Er, about 3.6 times the volume of the typical Indiana prescriber of this medication (33). Medicare paid an average of $28.72 per fill, versus $19.62 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 245 30-Day Fills standardized to 30-day supplies 6,957 Days of Medication total across all patients in 2023 | |||
| Pioglitazone Hcl | 104 | $26.49 | ▲ More than typical |
About Pioglitazone Hcl: Pioglitazone is a diabetes drug (thiazolidinedione-type, also called glitazones) used along with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes. Show more ▾ It works by helping to restore your body's proper response to insulin, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Pioglitazone is used either alone or in combination with other diabetes medications (such as metformin or a sulfonylurea such as glyburide). Talk to your doctor about the risks and benefits of pioglitazone. In 2023, this provider wrote 104 Medicare prescriptions for Pioglitazone Hcl, about 3 times the volume of the typical Indiana prescriber of this medication (35). Medicare paid an average of $26.49 per fill, versus $18.28 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 256 30-Day Fills standardized to 30-day supplies 7,600 Days of Medication total across all patients in 2023 | |||
| Victoza 3-PakLiraglutide | 104 | $1,482.47▼ below IN avg | ▲ More than typical |
About Victoza 3-Pak: This medication is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. Show more ▾ It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Liraglutide is similar to a natural hormone in your body (incretin). It works by controlling your appetite. An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN. In 2023, this provider wrote 104 Medicare prescriptions for Victoza 3-Pak, about 5 times the volume of the typical Indiana prescriber of this medication (21). Medicare paid an average of $1,482.47 per fill, versus $1,787.38 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 138.5 30-Day Fills standardized to 30-day supplies 4,155 Days of Medication total across all patients in 2023 | |||
| Losartan Potassium | 103 | $18.42 | ≈ Typical |
About Losartan Potassium: Losartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. Show more ▾ It is also used to lower the risk of strokes in patients with high blood pressure and an enlarged heart. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Losartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily. An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II. In 2023, this provider wrote 103 Medicare prescriptions for Losartan Potassium, about the same volume as the typical Indiana prescriber of this medication (106). Medicare paid an average of $18.42 per fill, versus $10.81 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 300 30-Day Fills standardized to 30-day supplies 8,989 Days of Medication total across all patients in 2023 | |||
| Rosuvastatin Calcium | 99 | $26.60 | ≈ Typical |
About Rosuvastatin Calcium: Rosuvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks. In addition to eating a proper diet (such as a low cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Talk with your doctor for more details. A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES. In 2023, this provider wrote 99 Medicare prescriptions for Rosuvastatin Calcium, about 1.2 times the volume of the typical Indiana prescriber of this medication (85). Medicare paid an average of $26.60 per fill, versus $24.43 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 233 30-Day Fills standardized to 30-day supplies 6,990 Days of Medication total across all patients in 2023 | |||
| Ulticare Pen NeedlePen Needle, Diabetic | 94 | $52.88▼ below IN avg | ▲ More than typical |
In 2023, this provider wrote 94 Medicare prescriptions for Ulticare Pen Needle, about 4.9 times the volume of the typical Indiana prescriber of this medication (19). Medicare paid an average of $52.88 per fill, versus $58.64 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 114.8 30-Day Fills standardized to 30-day supplies 3,313 Days of Medication total across all patients in 2023 | |||
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 93 | $104.55 | ▲ More than typical |
In 2023, this provider wrote 93 Medicare prescriptions for Ultra-Fine Short Pen Needle, about 4.4 times the volume of the typical Indiana prescriber of this medication (21). Medicare paid an average of $104.55 per fill, versus $91.92 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 170.8 30-Day Fills standardized to 30-day supplies 5,090 Days of Medication total across all patients in 2023 | |||
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 92 | $663.83▼ below IN avg | ▲ More than typical |
About Toujeo Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 92 Medicare prescriptions for Toujeo Solostar, about 4 times the volume of the typical Indiana prescriber of this medication (23). Medicare paid an average of $663.83 per fill, versus $866.48 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 204.2 30-Day Fills standardized to 30-day supplies 6,129 Days of Medication total across all patients in 2023 | |||
| Levemir FlexpenInsulin Detemir | 87 | $1,040.17 | – No State Data |
About Levemir Flexpen: Insulin detemir is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin detemir is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin detemir may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs (such as metformin, exenatide). A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS. In 2023, this provider wrote 87 Medicare prescriptions for Levemir Flexpen. Medicare paid an average of $1,040.17 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $1,040.17 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 159 30-Day Fills standardized to 30-day supplies 4,734 Days of Medication total across all patients in 2023 | |||
| Bydureon BciseExenatide Microspheres | 81 | $1,235.34▼ below IN avg | ▲ More than typical |
About Bydureon Bcise: Exenatide is used either alone or with other medications, and with a proper diet and exercise program, to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Exenatide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high sugar (such as after a meal) and decreasing the amount of sugar your liver makes. Exenatide is not a substitute for insulin if you require insulin treatment. In 2023, this provider wrote 81 Medicare prescriptions for Bydureon Bcise, about 4 times the volume of the typical Indiana prescriber of this medication (20). Medicare paid an average of $1,235.34 per fill, versus $1,274.79 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 120.6 30-Day Fills standardized to 30-day supplies 3,524 Days of Medication total across all patients in 2023 | |||
| Tresiba Flextouch U-200Insulin Degludec | 73 | $1,333.47▼ below IN avg | ▲ More than typical |
About Tresiba Flextouch U-200: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2023, this provider wrote 73 Medicare prescriptions for Tresiba Flextouch U-200, about 2.7 times the volume of the typical Indiana prescriber of this medication (27). Medicare paid an average of $1,333.47 per fill, versus $1,395.75 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 155.3 30-Day Fills standardized to 30-day supplies 4,621 Days of Medication total across all patients in 2023 | |||
| Glipizide | 68 | $17.03 | ▲ More than typical |
About Glipizide: Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. An oral hypoglycemic agent which is rapidly absorbed and completely metabolized. In 2023, this provider wrote 68 Medicare prescriptions for Glipizide, about 2 times the volume of the typical Indiana prescriber of this medication (34). Medicare paid an average of $17.03 per fill, versus $8.03 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 199.5 30-Day Fills standardized to 30-day supplies 5,985 Days of Medication total across all patients in 2023 | |||
| V-Go 40Sub-Q Insulin Device, 40 Unit | 65 | $633.47▼ below IN avg | ▲ More than typical |
In 2023, this provider wrote 65 Medicare prescriptions for V-Go 40, about 2.6 times the volume of the typical Indiana prescriber of this medication (25). Medicare paid an average of $633.47 per fill, versus $705.75 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 83 30-Day Fills standardized to 30-day supplies 2,490 Days of Medication total across all patients in 2023 | |||
| Fenofibrate | 63 | $36.84▼ below IN avg | ▲ More than typical |
About Fenofibrate: Fenofibrate is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. Show more ▾ It works by increasing the natural substance (enzyme) that breaks down fats in the blood. Fenofibrate belongs to a group of drugs known as fibrates. Lowering triglycerides in people with very high triglyceride blood levels may decrease the risk of pancreas disease (pancreatitis). However, fenofibrate might not lower your risk of a heart attack or stroke. Talk to your doctor about the risks and benefits of fenofibrate. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. An antilipemic agent which reduces both CHOLESTEROL and TRIGLYCERIDES in the blood. In 2023, this provider wrote 63 Medicare prescriptions for Fenofibrate, about 2.6 times the volume of the typical Indiana prescriber of this medication (24). Medicare paid an average of $36.84 per fill, versus $49.05 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 187 30-Day Fills standardized to 30-day supplies 5,610 Days of Medication total across all patients in 2023 | |||
| Metoprolol Succinate | 61 | $38.38 | ▼ Less than typical |
About Metoprolol Succinate: This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart. A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. In 2023, this provider wrote 61 Medicare prescriptions for Metoprolol Succinate, about half the volume of the typical Indiana prescriber of this medication (115). Medicare paid an average of $38.38 per fill, versus $19.91 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 181 30-Day Fills standardized to 30-day supplies 5,430 Days of Medication total across all patients in 2023 | |||
| Simvastatin | 60 | $11.71 | ≈ Typical |
About Simvastatin: Simvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. A derivative of LOVASTATIN and potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It may also interfere with steroid hormone production. Due to the induction of hepatic LDL RECEPTORS, it increases breakdown of LDL CHOLESTEROL. In 2023, this provider wrote 60 Medicare prescriptions for Simvastatin, about 80% of the volume of the typical Indiana prescriber of this medication (75). Medicare paid an average of $11.71 per fill, versus $8.18 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 180 30-Day Fills standardized to 30-day supplies 5,400 Days of Medication total across all patients in 2023 | |||
| Humulin R U-500Insulin Regular, Human | 56 | $1,972.60▼ below IN avg | ▲ More than typical |
About Humulin R U-500: Inhaled insulin powder is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a short-acting insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This product is absorbed into the blood through your lungs. It starts working faster and lasts for a shorter time than regular insulin injected under the skin. It is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin). In 2023, this provider wrote 56 Medicare prescriptions for Humulin R U-500, about 2.7 times the volume of the typical Indiana prescriber of this medication (21). Medicare paid an average of $1,972.60 per fill, versus $2,305.02 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 68.9 30-Day Fills standardized to 30-day supplies 2,042 Days of Medication total across all patients in 2023 | |||
| Pantoprazole Sodium | 55 | $10.57▼ below IN avg | ▼ Less than typical |
About Pantoprazole Sodium: Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). Show more ▾ It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER. In 2023, this provider wrote 55 Medicare prescriptions for Pantoprazole Sodium, about 64% of the volume of the typical Indiana prescriber of this medication (86). Medicare paid an average of $10.57 per fill, versus $15.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 91 30-Day Fills standardized to 30-day supplies 2,708 Days of Medication total across all patients in 2023 | |||
| Gabapentin | 53 | $17.89▼ below IN avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2023, this provider wrote 53 Medicare prescriptions for Gabapentin, about half the volume of the typical Indiana prescriber of this medication (107). Medicare paid an average of $17.89 per fill, versus $20.83 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 85 30-Day Fills standardized to 30-day supplies 2,550 Days of Medication total across all patients in 2023 | |||
| Ultra-Fine Nano Pen NeedlePen Needle, Diabetic | 51 | $111.96 | ▲ More than typical |
In 2023, this provider wrote 51 Medicare prescriptions for Ultra-Fine Nano Pen Needle, about 2.6 times the volume of the typical Indiana prescriber of this medication (20). Medicare paid an average of $111.96 per fill, versus $93.47 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 111.9 30-Day Fills standardized to 30-day supplies 3,314 Days of Medication total across all patients in 2023 | |||
| V-Go 20Sub-Q Insulin Device, 20 Unit | 46 | $820.94▼ below IN avg | ▲ More than typical |
In 2023, this provider wrote 46 Medicare prescriptions for V-Go 20, about 1.4 times the volume of the typical Indiana prescriber of this medication (34). Medicare paid an average of $820.94 per fill, versus $853.82 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 74 30-Day Fills standardized to 30-day supplies 2,220 Days of Medication total across all patients in 2023 | |||
| Spironolactone | 45 | $20.77 | ≈ Typical |
About Spironolactone: Spironolactone is used to treat high blood pressure and heart failure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat swelling (edema) caused by certain conditions (such as heart failure, liver disease) by removing excess fluid and improving symptoms such as breathing problems. This medication is also used to treat conditions in which the body is making too much of a natural substance (aldosterone). Spironolactone is known as a water pill (potassium-sparing diuretic). A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827) In 2023, this provider wrote 45 Medicare prescriptions for Spironolactone, about the same volume as the typical Indiana prescriber of this medication (48). Medicare paid an average of $20.77 per fill, versus $13.56 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 103 30-Day Fills standardized to 30-day supplies 3,090 Days of Medication total across all patients in 2023 | |||
| Methimazole | 43 | $18.89 | ≈ Typical |
About Methimazole: Methimazole is used to treat overactive thyroid (hyperthyroidism). Show more ▾ It works by stopping the thyroid gland from making too much thyroid hormone. A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme. In 2023, this provider wrote 43 Medicare prescriptions for Methimazole, about the same volume as the typical Indiana prescriber of this medication (39). Medicare paid an average of $18.89 per fill, versus $13.39 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 89 30-Day Fills standardized to 30-day supplies 2,670 Days of Medication total across all patients in 2023 | |||
| Alendronate Sodium | 43 | $7.65▼ below IN avg | ≈ Typical |
About Alendronate Sodium: Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. In 2023, this provider wrote 43 Medicare prescriptions for Alendronate Sodium, about 90% of the volume of the typical Indiana prescriber of this medication (48). Medicare paid an average of $7.65 per fill, versus $10.54 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 106 30-Day Fills standardized to 30-day supplies 3,164 Days of Medication total across all patients in 2023 | |||
| Insulin SyringeSyringe And Needle,insulin,1ml | 41 | $62.70 | ▲ More than typical |
In 2023, this provider wrote 41 Medicare prescriptions for Insulin Syringe, about 2.9 times the volume of the typical Indiana prescriber of this medication (14). Medicare paid an average of $62.70 per fill, versus $50.72 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 88.1 30-Day Fills standardized to 30-day supplies 2,633 Days of Medication total across all patients in 2023 | |||
| Metoprolol Tartrate | 38 | $11.49 | ▼ Less than typical |
About Metoprolol Tartrate: Metoprolol is used with or without other medications to treat high blood pressure (hypertension). Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This medication is also used to treat chest pain (angina) and to improve survival after a heart attack. Metoprolol belongs to a class of drugs known as beta blockers. It works by blocking the action of certain natural chemicals in your body, such as epinephrine, on the heart and blood vessels. This effect lowers the heart rate, blood pressure, and strain on the heart. A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. In 2023, this provider wrote 38 Medicare prescriptions for Metoprolol Tartrate, about half the volume of the typical Indiana prescriber of this medication (80). Medicare paid an average of $11.49 per fill, versus $7.72 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 114 30-Day Fills standardized to 30-day supplies 3,420 Days of Medication total across all patients in 2023 | |||
| Amlodipine Besylate | 38 | $10.78 | ▼ Less than typical |
About Amlodipine Besylate: Amlodipine is used with or without other medications to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Amlodipine belongs to a class of drugs known as calcium channel blockers. It works by relaxing blood vessels so blood can flow more easily. Amlodipine is also used to prevent certain types of chest pain (angina). It may help to increase your ability to exercise and decrease the frequency of angina attacks. It should not be used to treat attacks of chest pain when they occur. Use other medications (such as sublingual nitroglycerin) to relieve attacks of chest pain as directed by your doctor. A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION. In 2023, this provider wrote 38 Medicare prescriptions for Amlodipine Besylate, about a quarter of the volume of the typical Indiana prescriber of this medication (154). Medicare paid an average of $10.78 per fill, versus $6.78 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 106 30-Day Fills standardized to 30-day supplies 3,180 Days of Medication total across all patients in 2023 | |||
| Omeprazole | 37 | $15.32 | ▼ Less than typical |
About Omeprazole: Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). Show more ▾ It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). If you are self-treating with this medication, over-the-counter omeprazole products are used to treat frequent heartburn (occurring 2 or more days a week). Since it may take 1 to 4 days to have full effect, these products do not relieve heartburn right away. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar brand names may contain different ingredients meant for different purposes. Taking the wrong product could harm you. A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. In 2023, this provider wrote 37 Medicare prescriptions for Omeprazole, about a third of the volume of the typical Indiana prescriber of this medication (109). Medicare paid an average of $15.32 per fill, versus $14.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 103 30-Day Fills standardized to 30-day supplies 3,090 Days of Medication total across all patients in 2023 | |||
| Hydrochlorothiazide | 37 | $6.82 | ▼ Less than typical |
About Hydrochlorothiazide: This medication is used to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Hydrochlorothiazide belongs to a class of drugs known as diuretics/water pills. It works by causing you to make more urine. This helps your body get rid of extra salt and water. This medication also reduces extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, or kidney disease. This can lessen symptoms such as shortness of breath or swelling in your ankles or feet. A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism. In 2023, this provider wrote 37 Medicare prescriptions for Hydrochlorothiazide, about half the volume of the typical Indiana prescriber of this medication (78). Medicare paid an average of $6.82 per fill, versus $5.00 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 91 30-Day Fills standardized to 30-day supplies 2,730 Days of Medication total across all patients in 2023 | |||
| Tolvaptan | 35 | $5,917.54▼ below IN avg | ▲ More than typical |
About Tolvaptan: This medication is used by people who have a certain inherited kidney problem (autosomal dominant polycystic kidney disease-ADPKD). Show more ▾ This inherited kidney problem leads to the growth of fluid-filled sacs (cysts) in your kidneys. Over time, the cysts grow in size, which can damage the way your kidneys work and lead to kidney failure. Tolvaptan belongs to a class of drugs known as vasopressin receptor antagonists. It works by slowing the growth of kidney cysts caused by ADPKD. This effect helps protect your kidneys from damage and failure. Different brands of this medication have different uses. Do not change brands of this medication unless directed by your doctor. A benzazepine derivative and selective VASOPRESSIN V2 RECEPTOR antagonist that is used to treat euvolemic and hypervolemic HYPONATREMIA. It is also used in the treatment of rapidly progressing AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE to slow the rate of cyst development and renal insufficiency. In 2023, this provider wrote 35 Medicare prescriptions for Tolvaptan, about 1.8 times the volume of the typical Indiana prescriber of this medication (19). Medicare paid an average of $5,917.54 per fill, versus $9,341.38 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 35.1 30-Day Fills standardized to 30-day supplies 1,051 Days of Medication total across all patients in 2023 | |||
| LevemirInsulin Detemir | 34 | $1,359.13 | ▲ More than typical |
About Levemir: Insulin detemir is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin detemir is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin detemir may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs (such as metformin, exenatide). A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS. In 2023, this provider wrote 34 Medicare prescriptions for Levemir, about 1.5 times the volume of the typical Indiana prescriber of this medication (23). Medicare paid an average of $1,359.13 per fill, versus $600.32 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 50.8 30-Day Fills standardized to 30-day supplies 1,479 Days of Medication total across all patients in 2023 | |||
| SynthroidLevothyroxine Sodium | 33 | $74.87 | ≈ Typical |
About Synthroid: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2023, this provider wrote 33 Medicare prescriptions for Synthroid, about 77% of the volume of the typical Indiana prescriber of this medication (43). Medicare paid an average of $74.87 per fill, versus $63.93 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 89 30-Day Fills standardized to 30-day supplies 2,670 Days of Medication total across all patients in 2023 | |||
| Victoza 2-PakLiraglutide | 33 | $838.39▼ below IN avg | ▲ More than typical |
About Victoza 2-Pak: This medication is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. Show more ▾ It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Liraglutide is similar to a natural hormone in your body (incretin). It works by controlling your appetite. An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN. In 2023, this provider wrote 33 Medicare prescriptions for Victoza 2-Pak, about 1.8 times the volume of the typical Indiana prescriber of this medication (18). Medicare paid an average of $838.39 per fill, versus $838.65 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 33 30-Day Fills standardized to 30-day supplies 960 Days of Medication total across all patients in 2023 | |||
| Sure Comfort Pen NeedlePen Needle, Diabetic | 32 | $71.57 | ▲ More than typical |
In 2023, this provider wrote 32 Medicare prescriptions for Sure Comfort Pen Needle, about 1.9 times the volume of the typical Indiana prescriber of this medication (17). Medicare paid an average of $71.57 per fill, versus $39.81 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 53.4 30-Day Fills standardized to 30-day supplies 1,591 Days of Medication total across all patients in 2023 | |||
| Pravastatin Sodium | 32 | $14.88▼ below IN avg | ▼ Less than typical |
About Pravastatin Sodium: Pravastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. An antilipemic fungal metabolite isolated from cultures of Nocardia autotrophica. It acts as a competitive inhibitor of HMG CoA reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES). In 2023, this provider wrote 32 Medicare prescriptions for Pravastatin Sodium, about half the volume of the typical Indiana prescriber of this medication (61). Medicare paid an average of $14.88 per fill, versus $16.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 76 30-Day Fills standardized to 30-day supplies 2,280 Days of Medication total across all patients in 2023 | |||
| Comfort Ez Pen NeedlePen Needle, Diabetic | 31 | $158.93 | ▲ More than typical |
In 2023, this provider wrote 31 Medicare prescriptions for Comfort Ez Pen Needle, about 1.7 times the volume of the typical Indiana prescriber of this medication (18). Medicare paid an average of $158.93 per fill, versus $139.61 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 55.9 30-Day Fills standardized to 30-day supplies 1,636 Days of Medication total across all patients in 2023 | |||
| Lyumjev Kwikpen U-100Insulin Lispro-Aabc | 31 | $679.60▼ below IN avg | ▲ More than typical |
About Lyumjev Kwikpen U-100: Insulin lispro-aabc is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro-aabc is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro-aabc starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro-aabc may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). In 2023, this provider wrote 31 Medicare prescriptions for Lyumjev Kwikpen U-100, about 1.8 times the volume of the typical Indiana prescriber of this medication (17). Medicare paid an average of $679.60 per fill, versus $1,071.02 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 82.1 30-Day Fills standardized to 30-day supplies 2,463 Days of Medication total across all patients in 2023 | |||
| Omnipod 5 G6 Pods (Gen 5)Insulin Pump Cart,automated,bt | 31 | $1,594.36 | ▲ More than typical |
In 2023, this provider wrote 31 Medicare prescriptions for Omnipod 5 G6 Pods (Gen 5), about 1.9 times the volume of the typical Indiana prescriber of this medication (16). Medicare paid an average of $1,594.36 per fill, versus $1,068.70 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 65 30-Day Fills standardized to 30-day supplies 1,950 Days of Medication total across all patients in 2023 | |||
| Pen NeedlePen Needle, Diabetic | 30 | $27.62▼ below IN avg | ▲ More than typical |
In 2023, this provider wrote 30 Medicare prescriptions for Pen Needle, about 1.7 times the volume of the typical Indiana prescriber of this medication (18). Medicare paid an average of $27.62 per fill, versus $30.41 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 54.2 30-Day Fills standardized to 30-day supplies 1,626 Days of Medication total across all patients in 2023 | |||
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 30 | $638.21▼ below IN avg | ▲ More than typical |
About Fiasp Flextouch: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. In 2023, this provider wrote 30 Medicare prescriptions for Fiasp Flextouch, about 1.5 times the volume of the typical Indiana prescriber of this medication (20). Medicare paid an average of $638.21 per fill, versus $1,138.51 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 58.3 30-Day Fills standardized to 30-day supplies 1,749 Days of Medication total across all patients in 2023 | |||
| V-Go 30Sub-Q Insulin Device, 30 Unit | 28 | $890.69 | ▲ More than typical |
In 2023, this provider wrote 28 Medicare prescriptions for V-Go 30, about 1.6 times the volume of the typical Indiana prescriber of this medication (18). Medicare paid an average of $890.69 per fill, versus $647.44 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 52 30-Day Fills standardized to 30-day supplies 1,560 Days of Medication total across all patients in 2023 | |||
| Lovastatin | 27 | $29.83 | ≈ Typical |
About Lovastatin: Lovastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver. In 2023, this provider wrote 27 Medicare prescriptions for Lovastatin, about the same volume as the typical Indiana prescriber of this medication (26). Medicare paid an average of $29.83 per fill, versus $10.14 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 81 30-Day Fills standardized to 30-day supplies 2,430 Days of Medication total across all patients in 2023 | |||
| Insulin SyringeSyring-Needl,disp,insul,0.3 Ml | 27 | $56.33 | ▲ More than typical |
In 2023, this provider wrote 27 Medicare prescriptions for Insulin Syringe, about 1.9 times the volume of the typical Indiana prescriber of this medication (14). Medicare paid an average of $56.33 per fill, versus $50.72 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 43.1 30-Day Fills standardized to 30-day supplies 1,294 Days of Medication total across all patients in 2023 | |||
| Repatha SyringeEvolocumab | 26 | $769.31 | ▲ More than typical |
About Repatha Syringe: Evolocumab is used along with a proper diet to help lower bad cholesterol (LDL) in the blood. Show more ▾ It may be used with other LDL-lowering treatments (such as statin drugs, ezetimibe, LDL apheresis). Evolocumab is also used by people who have heart disease to help prevent heart attacks and strokes. This medication belongs to a class of drugs known as monoclonal antibodies. It works by improving how well your body gets rid of LDL cholesterol. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. In 2023, this provider wrote 26 Medicare prescriptions for Repatha Syringe, about 1.5 times the volume of the typical Indiana prescriber of this medication (17). Medicare paid an average of $769.31 per fill, versus $727.13 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36.8 30-Day Fills standardized to 30-day supplies 1,064 Days of Medication total across all patients in 2023 | |||
| Insulin Lispro Kwikpen U-100Insulin Lispro | 26 | $174.18▼ below IN avg | ≈ Typical |
About Insulin Lispro Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2023, this provider wrote 26 Medicare prescriptions for Insulin Lispro Kwikpen U-100, about 90% of the volume of the typical Indiana prescriber of this medication (29). Medicare paid an average of $174.18 per fill, versus $209.96 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 42.7 30-Day Fills standardized to 30-day supplies 1,271 Days of Medication total across all patients in 2023 | |||
| ForteoTeriparatide | 24 | $4,126.03▼ below IN avg | ≈ Typical |
About Forteo: Teriparatide is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Show more ▾ It is similar to a natural hormone in your body (parathyroid hormone). It works by increasing bone mass and strength. This effect helps to decrease the risk of getting a fracture. This medication is not recommended for use in children or young adults whose bones are still growing. A polypeptide that consists of the 1-34 amino-acid fragment of human PARATHYROID HORMONE, the biologically active N-terminal region. The acetate form is given by intravenous infusion in the differential diagnosis of HYPOPARATHYROIDISM and PSEUDOHYPOPARATHYROIDISM. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) In 2023, this provider wrote 24 Medicare prescriptions for Forteo, about the same volume as the typical Indiana prescriber of this medication (22). Medicare paid an average of $4,126.03 per fill, versus $4,426.48 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 24 30-Day Fills standardized to 30-day supplies 688 Days of Medication total across all patients in 2023 | |||
| RybelsusSemaglutide | 23 | $1,194.29▼ below IN avg | ≈ Typical |
About Rybelsus: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment. In 2023, this provider wrote 23 Medicare prescriptions for Rybelsus, about the same volume as the typical Indiana prescriber of this medication (22). Medicare paid an average of $1,194.29 per fill, versus $1,389.67 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 27 30-Day Fills standardized to 30-day supplies 810 Days of Medication total across all patients in 2023 | |||
| Insulin Lispro | 22 | $115.01▼ below IN avg | ≈ Typical |
About Insulin Lispro: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2023, this provider wrote 22 Medicare prescriptions for Insulin Lispro, about 88% of the volume of the typical Indiana prescriber of this medication (25). Medicare paid an average of $115.01 per fill, versus $187.20 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 30.7 30-Day Fills standardized to 30-day supplies 921 Days of Medication total across all patients in 2023 | |||
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 22 | $1,930.06 | ≈ Typical |
About Novolog Mix 70-30 Flexpen: Insulin aspart protamine/insulin aspart is used along with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ This product is a combination of two man-made insulins: intermediate-acting insulin aspart protamine and rapid-acting insulin aspart. This combination starts working faster and lasts for a longer time than regular insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. It replaces the insulin that your body no longer produces, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. In 2023, this provider wrote 22 Medicare prescriptions for Novolog Mix 70-30 Flexpen, about the same volume as the typical Indiana prescriber of this medication (22). Medicare paid an average of $1,930.06 per fill, versus $1,664.98 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 37.2 30-Day Fills standardized to 30-day supplies 1,046 Days of Medication total across all patients in 2023 | |||
| Insulin SyringeSyringe-Needle,insulin,0.5 Ml | 22 | $81.75 | ▲ More than typical |
In 2023, this provider wrote 22 Medicare prescriptions for Insulin Syringe, about 1.6 times the volume of the typical Indiana prescriber of this medication (14). Medicare paid an average of $81.75 per fill, versus $50.72 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 48.9 30-Day Fills standardized to 30-day supplies 1,468 Days of Medication total across all patients in 2023 | |||
| Testosterone | 21 | $461.73 | ≈ Typical |
About Testosterone: This medicated patch contains testosterone. Show more ▾ It is used for hormone replacement in men who are not able to produce enough testosterone (for example, due to hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels. Testosterone helps the body to develop and maintain the male sexual characteristics (masculinity), such as a deep voice and body hair. It also helps to maintain muscle and prevent bone loss, and is necessary for natural sexual ability/desire. This drug should not be used by women. A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. In 2023, this provider wrote 21 Medicare prescriptions for Testosterone, about the same volume as the typical Indiana prescriber of this medication (19). Medicare paid an average of $461.73 per fill, versus $299.32 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 31 30-Day Fills standardized to 30-day supplies 910 Days of Medication total across all patients in 2023 | |||
| Trueplus Pen NeedlePen Needle, Diabetic | 21 | $35.18 | ≈ Typical |
In 2023, this provider wrote 21 Medicare prescriptions for Trueplus Pen Needle, about 1.2 times the volume of the typical Indiana prescriber of this medication (18). Medicare paid an average of $35.18 per fill, versus $25.95 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 45.9 30-Day Fills standardized to 30-day supplies 1,362 Days of Medication total across all patients in 2023 | |||
| Xigduo XrDapaglifloz Propaned/Metformin | 21 | $596.95▼ below IN avg | ≈ Typical |
About Xigduo Xr: This medication is a combination of 2 drugs: dapagliflozin and metformin. Show more ▾ It is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used to treat kidney disease or heart failure in people with type 2 diabetes. It may help you live longer and lower your risk of going to the hospital for heart failure. This medication works by helping to restore your body's proper response to the insulin you naturally produce. It also increases the removal of sugar by your kidneys, decreases how much sugar is made in your liver, and decreases how much sugar your body takes in through your stomach and intestines. In 2023, this provider wrote 21 Medicare prescriptions for Xigduo Xr, about the same volume as the typical Indiana prescriber of this medication (23). Medicare paid an average of $596.95 per fill, versus $880.85 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 35 30-Day Fills standardized to 30-day supplies 1,050 Days of Medication total across all patients in 2023 | |||
| Easy Touch Pen NeedlePen Needle, Diabetic | 20 | $75.31 | ▲ More than typical |
In 2023, this provider wrote 20 Medicare prescriptions for Easy Touch Pen Needle, about 1.3 times the volume of the typical Indiana prescriber of this medication (15). Medicare paid an average of $75.31 per fill, versus $60.64 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 38.6 30-Day Fills standardized to 30-day supplies 1,120 Days of Medication total across all patients in 2023 | |||
| Dropsafe Prep PadsAlcohol Antiseptic Pads | 20 | $4.11 | ▲ More than typical |
In 2023, this provider wrote 20 Medicare prescriptions for Dropsafe Prep Pads, about 1.4 times the volume of the typical Indiana prescriber of this medication (14). Medicare paid an average of $4.11 per fill, versus $3.80 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 59.8 30-Day Fills standardized to 30-day supplies 1,795 Days of Medication total across all patients in 2023 | |||
| Liothyronine Sodium | 19 | $28.08▼ below IN avg | ▼ Less than typical |
About Liothyronine Sodium: Liothyronine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally made by the thyroid gland. Liothyronine is a man-made form of thyroid hormone. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone helps you stay healthy. For children, having enough thyroid hormone helps them grow and learn normally. This medication is also used to treat other types of thyroid problems (such as certain types of goiters, thyroid cancer). It can also be used to test for certain types of thyroid disease. This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3. In 2023, this provider wrote 19 Medicare prescriptions for Liothyronine Sodium, about 66% of the volume of the typical Indiana prescriber of this medication (29). Medicare paid an average of $28.08 per fill, versus $53.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 31 30-Day Fills standardized to 30-day supplies 930 Days of Medication total across all patients in 2023 | |||
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 19 | $33.78 | ▼ Less than typical |
About Lisinopril-Hydrochlorothiazide: This medication is used to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This product contains two medications: lisinopril and hydrochlorothiazide. Lisinopril is an ACE inhibitor and works by relaxing blood vessels so that blood can flow more easily. Hydrochlorothiazide is a water pill (diuretic) that causes you to make more urine, which helps your body get rid of extra salt and water. This product is used when one drug is not controlling your blood pressure. Your doctor may direct you to take the individual medications first, and then switch you to this combination product. Do not continue taking the individual medications (lisinopril and/or hydrochlorothiazide) after you start this medication. In 2023, this provider wrote 19 Medicare prescriptions for Lisinopril-Hydrochlorothiazide, about a third of the volume of the typical Indiana prescriber of this medication (47). Medicare paid an average of $33.78 per fill, versus $7.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 57 30-Day Fills standardized to 30-day supplies 1,710 Days of Medication total across all patients in 2023 | |||
| Cinacalcet Hcl | 19 | $310.12▼ below IN avg | ▼ Less than typical |
About Cinacalcet Hcl: Cinacalcet is used to treat increased amounts of a certain hormone (parathyroid) in people with long-term kidney disease who are on dialysis. Show more ▾ It is also used to treat increased amounts of calcium in people with an overactive parathyroid gland or in people with cancer of the parathyroid gland. Cinacalcet works by decreasing the amount of parathyroid hormone, calcium, and phosphorus in your body. Having the right amount of these substances in your body helps to prevent bone disease. In 2023, this provider wrote 19 Medicare prescriptions for Cinacalcet Hcl, about 68% of the volume of the typical Indiana prescriber of this medication (28). Medicare paid an average of $310.12 per fill, versus $429.13 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 29 30-Day Fills standardized to 30-day supplies 870 Days of Medication total across all patients in 2023 | |||
| Fluconazole | 18 | $2.61▼ below IN avg | ≈ Typical |
About Fluconazole: Fluconazole is used to treat vaginal yeast infections. Show more ▾ It works by stopping the growth of common types of vaginal yeast (fungus). This medication belongs to a class of drugs called azole antifungals. Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS. In 2023, this provider wrote 18 Medicare prescriptions for Fluconazole, about 82% of the volume of the typical Indiana prescriber of this medication (22). Medicare paid an average of $2.61 per fill, versus $12.56 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 18 30-Day Fills standardized to 30-day supplies 38 Days of Medication total across all patients in 2023 | |||
| Cabergoline | 17 | $58.77▼ below IN avg | ▼ Less than typical |
About Cabergoline: This medication is used to treat high levels of prolactin hormone in your body. Show more ▾ High levels of prolactin in women can cause symptoms such as unwanted breast milk and missed periods and can cause difficulty becoming pregnant. High levels of prolactin in men can cause symptoms such as enlarged breasts and decreased sexual ability/desire. Cabergoline is an ergot medication and works by blocking the release of prolactin from the pituitary gland. An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion. It is used in the management of HYPERPROLACTINEMIA, and to suppress lactation following childbirth for medical reasons. Cabergoline is also used in the management of PARKINSON DISEASE. In 2023, this provider wrote 17 Medicare prescriptions for Cabergoline, about 65% of the volume of the typical Indiana prescriber of this medication (26). Medicare paid an average of $58.77 per fill, versus $166.05 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 30.9 30-Day Fills standardized to 30-day supplies 914 Days of Medication total across all patients in 2023 | |||
| Droplet Insulin SyringeSyringe And Needle,insulin,1ml | 17 | $59.36▼ below IN avg | ▲ More than typical |
In 2023, this provider wrote 17 Medicare prescriptions for Droplet Insulin Syringe, about 1.4 times the volume of the typical Indiana prescriber of this medication (12). Medicare paid an average of $59.36 per fill, versus $66.76 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 51 30-Day Fills standardized to 30-day supplies 1,530 Days of Medication total across all patients in 2023 | |||
| Repaglinide | 15 | $84.55 | ▼ Less than typical |
About Repaglinide: Repaglinide is used alone or with other medications to control high blood sugar along with a proper diet and exercise program. Show more ▾ It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. It works by stimulating the body to produce more insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. In 2023, this provider wrote 15 Medicare prescriptions for Repaglinide, about 63% of the volume of the typical Indiana prescriber of this medication (24). Medicare paid an average of $84.55 per fill, versus $48.71 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 45 30-Day Fills standardized to 30-day supplies 1,350 Days of Medication total across all patients in 2023 | |||
| Humulin NInsulin Nph Human Isophane | 15 | $759.63 | ≈ Typical |
In 2023, this provider wrote 15 Medicare prescriptions for Humulin N, about 75% of the volume of the typical Indiana prescriber of this medication (20). Medicare paid an average of $759.63 per fill, versus $371.02 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27.6 30-Day Fills standardized to 30-day supplies 818 Days of Medication total across all patients in 2023 | |||
| Humalog Kwikpen U-200Insulin Lispro | 15 | $1,399.12▼ below IN avg | ≈ Typical |
About Humalog Kwikpen U-200: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2023, this provider wrote 15 Medicare prescriptions for Humalog Kwikpen U-200, about 75% of the volume of the typical Indiana prescriber of this medication (20). Medicare paid an average of $1,399.12 per fill, versus $1,924.78 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 24.9 30-Day Fills standardized to 30-day supplies 743 Days of Medication total across all patients in 2023 | |||
| Ezetimibe | 14 | $61.58 | ▼ Less than typical |
About Ezetimibe: Ezetimibe is used along with a low cholesterol/low fat diet and exercise to help lower cholesterol in the blood. Show more ▾ Ezetimibe may be used alone or with other drugs (such as statins or fibrates). Ezetimibe works by reducing the amount of cholesterol your body absorbs from your diet. Reducing cholesterol may help prevent strokes and heart attacks. An azetidine derivative and ANTICHOLESTEREMIC AGENT that inhibits intestinal STEROL absorption. It is used to reduce total CHOLESTEROL; LDL CHOLESTEROL, and APOLIPOPROTEINS B in the treatment of HYPERLIPIDEMIAS. In 2023, this provider wrote 14 Medicare prescriptions for Ezetimibe, about a third of the volume of the typical Indiana prescriber of this medication (44). Medicare paid an average of $61.58 per fill, versus $59.64 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30 30-Day Fills standardized to 30-day supplies 900 Days of Medication total across all patients in 2023 | |||
| TradjentaLinagliptin | 14 | $585.07▼ below IN avg | ▼ Less than typical |
About Tradjenta: Linagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used by people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Linagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS. In 2023, this provider wrote 14 Medicare prescriptions for Tradjenta, about a third of the volume of the typical Indiana prescriber of this medication (39). Medicare paid an average of $585.07 per fill, versus $585.39 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 20 30-Day Fills standardized to 30-day supplies 437 Days of Medication total across all patients in 2023 | |||
| TresibaInsulin Degludec | 14 | $436.51▼ below IN avg | ≈ Typical |
About Tresiba: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2023, this provider wrote 14 Medicare prescriptions for Tresiba, about 88% of the volume of the typical Indiana prescriber of this medication (16). Medicare paid an average of $436.51 per fill, versus $589.83 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 16.6 30-Day Fills standardized to 30-day supplies 480 Days of Medication total across all patients in 2023 | |||
| FiaspInsulin Aspart (Niacinamide) | 13 | $874.67▼ below IN avg | ▼ Less than typical |
About Fiasp: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. In 2023, this provider wrote 13 Medicare prescriptions for Fiasp, about 65% of the volume of the typical Indiana prescriber of this medication (20). Medicare paid an average of $874.67 per fill, versus $1,519.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 21.4 30-Day Fills standardized to 30-day supplies 635 Days of Medication total across all patients in 2023 | |||
| Teriparatide | 13 | $2,597.86▼ below IN avg | ≈ Typical |
About Teriparatide: Teriparatide is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Show more ▾ It is similar to a natural hormone in your body (parathyroid hormone). It works by increasing bone mass and strength. This effect helps to decrease the risk of getting a fracture. This medication is not recommended for use in children or young adults whose bones are still growing. A polypeptide that consists of the 1-34 amino-acid fragment of human PARATHYROID HORMONE, the biologically active N-terminal region. The acetate form is given by intravenous infusion in the differential diagnosis of HYPOPARATHYROIDISM and PSEUDOHYPOPARATHYROIDISM. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) In 2023, this provider wrote 13 Medicare prescriptions for Teriparatide, about 81% of the volume of the typical Indiana prescriber of this medication (16). Medicare paid an average of $2,597.86 per fill, versus $2,889.60 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 13 30-Day Fills standardized to 30-day supplies 368 Days of Medication total across all patients in 2023 | |||
| BaqsimiGlucagon | 13 | $601.12 | ▼ Less than typical |
About Baqsimi: This medication is the same as your body's own glucagon, a natural substance that raises blood sugar by causing the body to release sugar stored in the liver. Show more ▾ It is used to treat very low blood sugar (hypoglycemia) that may cause you to need help from others. Make sure a family member or caregiver knows where you keep this medication and how to use it before you need their help. Peptides derived from proglucagon which is also the precursor of pancreatic GLUCAGON. Despite expression of proglucagon in multiple tissues, the major production site of glucagon-like peptides (GLPs) is the INTESTINAL L CELLS. GLPs include glucagon-like peptide 1, glucagon-like peptide 2, and the various truncated forms. In 2023, this provider wrote 13 Medicare prescriptions for Baqsimi, about half the volume of the typical Indiana prescriber of this medication (22). Medicare paid an average of $601.12 per fill, versus $530.25 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 361 Days of Medication total across all patients in 2023 | |||
| Novolin 70-30Insulin Nph Hum/Reg Insulin Hm | 13 | $463.37▼ below IN avg | ▼ Less than typical |
In 2023, this provider wrote 13 Medicare prescriptions for Novolin 70-30, about 72% of the volume of the typical Indiana prescriber of this medication (18). Medicare paid an average of $463.37 per fill, versus $570.22 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 19.8 30-Day Fills standardized to 30-day supplies 550 Days of Medication total across all patients in 2023 | |||
| Levemir FlextouchInsulin Detemir | 13 | $1,036.23 | ▼ Less than typical |
About Levemir Flextouch: Insulin detemir is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin detemir is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin detemir may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs (such as metformin, exenatide). A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS. In 2023, this provider wrote 13 Medicare prescriptions for Levemir Flextouch, about half the volume of the typical Indiana prescriber of this medication (27). Medicare paid an average of $1,036.23 per fill, versus $857.35 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25.4 30-Day Fills standardized to 30-day supplies 752 Days of Medication total across all patients in 2023 | |||
| Furosemide | 13 | $2.98▼ below IN avg | ▼ Less than typical |
About Furosemide: Furosemide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. Show more ▾ This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. This drug is also used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Furosemide is a water pill (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt. A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. In 2023, this provider wrote 13 Medicare prescriptions for Furosemide, about 13% of the volume of the typical Indiana prescriber of this medication (97). Medicare paid an average of $2.98 per fill, versus $5.71 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 27 30-Day Fills standardized to 30-day supplies 810 Days of Medication total across all patients in 2023 | |||
| JanumetSitagliptin Phos/Metformin Hcl | 13 | $875.85▼ below IN avg | ▼ Less than typical |
About Janumet: This combination medication is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. This product contains 2 medications. Sitagliptin works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. In 2023, this provider wrote 13 Medicare prescriptions for Janumet, about 68% of the volume of the typical Indiana prescriber of this medication (19). Medicare paid an average of $875.85 per fill, versus $919.43 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2023 | |||
| AfrezzaInsulin Regular, Human | 12 | $1,278.41 | – No State Data |
About Afrezza: Inhaled insulin powder is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a short-acting insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This product is absorbed into the blood through your lungs. It starts working faster and lasts for a shorter time than regular insulin injected under the skin. It is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin). In 2023, this provider wrote 12 Medicare prescriptions for Afrezza. Medicare paid an average of $1,278.41 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $1,278.41 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
| Atenolol | 12 | $11.47 | ▼ Less than typical |
About Atenolol: Atenolol is used with or without other medications to treat high blood pressure (hypertension). Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This medication is also used to treat chest pain (angina) and to improve survival after a heart attack. Atenolol belongs to a class of drugs known as beta blockers. It works by blocking the action of certain natural chemicals in your body, such as epinephrine, on the heart and blood vessels. This effect lowers the heart rate, blood pressure, and strain on the heart. A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect. In 2023, this provider wrote 12 Medicare prescriptions for Atenolol, about a third of the volume of the typical Indiana prescriber of this medication (40). Medicare paid an average of $11.47 per fill, versus $8.42 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36 30-Day Fills standardized to 30-day supplies 1,080 Days of Medication total across all patients in 2023 | |||
| Veo Insulin SyringeSyringe-Needle,insulin,0.5 Ml | 12 | $45.08▼ below IN avg | ≈ Typical |
In 2023, this provider wrote 12 Medicare prescriptions for Veo Insulin Syringe, about the same volume as the typical Indiana prescriber of this medication (13). Medicare paid an average of $45.08 per fill, versus $55.40 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 21.3 30-Day Fills standardized to 30-day supplies 640 Days of Medication total across all patients in 2023 | |||
| Janumet XrSitagliptin Phos/Metformin Hcl | 12 | $1,493.29 | ▼ Less than typical |
About Janumet Xr: This combination medication is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. This product contains 2 medications. Sitagliptin works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. In 2023, this provider wrote 12 Medicare prescriptions for Janumet Xr, about half the volume of the typical Indiana prescriber of this medication (21). Medicare paid an average of $1,493.29 per fill, versus $894.35 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36 30-Day Fills standardized to 30-day supplies 1,080 Days of Medication total across all patients in 2023 | |||
| Irbesartan | 12 | $83.76 | ▼ Less than typical |
About Irbesartan: Irbesartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Irbesartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily. A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease. In 2023, this provider wrote 12 Medicare prescriptions for Irbesartan, about a third of the volume of the typical Indiana prescriber of this medication (30). Medicare paid an average of $83.76 per fill, versus $28.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36 30-Day Fills standardized to 30-day supplies 1,080 Days of Medication total across all patients in 2023 | |||
| Insulin Aspart FlexpenInsulin Aspart | 12 | $425.30 | ▼ Less than typical |
About Insulin Aspart Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2023, this provider wrote 12 Medicare prescriptions for Insulin Aspart Flexpen, about half the volume of the typical Indiana prescriber of this medication (21). Medicare paid an average of $425.30 per fill, versus $220.12 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 26.3 30-Day Fills standardized to 30-day supplies 755 Days of Medication total across all patients in 2023 | |||
| Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro | 12 | $998.13▼ below IN avg | ▼ Less than typical |
About Humalog Mix 75-25 Kwikpen: Insulin lispro protamine/insulin lispro is used along with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ This product is a combination of two man-made insulins: intermediate-acting insulin lispro protamine and rapid-acting insulin lispro. This combination starts working faster and lasts for a longer time than regular insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. It replaces the insulin that your body no longer produces, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. In 2023, this provider wrote 12 Medicare prescriptions for Humalog Mix 75-25 Kwikpen, about half the volume of the typical Indiana prescriber of this medication (22). Medicare paid an average of $998.13 per fill, versus $1,305.94 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 18.3 30-Day Fills standardized to 30-day supplies 548 Days of Medication total across all patients in 2023 | |||
| Telmisartan | 12 | $61.93 | ▼ Less than typical |
About Telmisartan: This medication is used to treat high blood pressure (hypertension). Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Telmisartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so blood can flow more easily. A biphenyl compound and benzimidazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION. In 2023, this provider wrote 12 Medicare prescriptions for Telmisartan, about half the volume of the typical Indiana prescriber of this medication (26). Medicare paid an average of $61.93 per fill, versus $43.86 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36 30-Day Fills standardized to 30-day supplies 1,080 Days of Medication total across all patients in 2023 | |||
| Humulin R U-500 KwikpenInsulin Regular, Human | 11 | $2,023.60▼ below IN avg | ▼ Less than typical |
About Humulin R U-500 Kwikpen: Inhaled insulin powder is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a short-acting insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This product is absorbed into the blood through your lungs. It starts working faster and lasts for a shorter time than regular insulin injected under the skin. It is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin). In 2023, this provider wrote 11 Medicare prescriptions for Humulin R U-500 Kwikpen, about a third of the volume of the typical Indiana prescriber of this medication (30). Medicare paid an average of $2,023.60 per fill, versus $2,323.50 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 11.6 30-Day Fills standardized to 30-day supplies 302 Days of Medication total across all patients in 2023 | |||
| Carvedilol | 11 | $5.40▼ below IN avg | ▼ Less than typical |
About Carvedilol: Carvedilol is used to treat high blood pressure and heart failure. Show more ▾ It is also used after a heart attack to improve the chance of survival if your heart is not pumping well. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural substances in your body, such as epinephrine, on the heart and blood vessels. This effect lowers your heart rate, blood pressure, and strain on your heart. Carvedilol belongs to a class of drugs known as alpha and beta blockers. A carbazole and propanol derivative that acts as a non-cardioselective beta blocker and vasodilator. It has blocking activity for ALPHA 1 ADRENERGIC RECEPTORS and, at higher doses, may function as a blocker of CALCIUM CHANNELS; it also has antioxidant properties. Carvedilol is used in the treatment of HYPERTENSION; ANGINA PECTORIS; and HEART FAILURE. It can also reduce the risk of death following MYOCARDIAL INFARCTION. In 2023, this provider wrote 11 Medicare prescriptions for Carvedilol, about 14% of the volume of the typical Indiana prescriber of this medication (81). Medicare paid an average of $5.40 per fill, versus $10.71 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 31 30-Day Fills standardized to 30-day supplies 930 Days of Medication total across all patients in 2023 | |||
| Humulin 70-30Insulin Nph Hum/Reg Insulin Hm | 11 | $754.47 | ▼ Less than typical |
In 2023, this provider wrote 11 Medicare prescriptions for Humulin 70-30, about 69% of the volume of the typical Indiana prescriber of this medication (16). Medicare paid an average of $754.47 per fill, versus $470.28 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12.1 30-Day Fills standardized to 30-day supplies 331 Days of Medication total across all patients in 2023 | |||
| Repatha SureclickEvolocumab | 11 | $742.06▼ below IN avg | ▼ Less than typical |
About Repatha Sureclick: Evolocumab is used along with a proper diet to help lower bad cholesterol (LDL) in the blood. Show more ▾ It may be used with other LDL-lowering treatments (such as statin drugs, ezetimibe, LDL apheresis). Evolocumab is also used by people who have heart disease to help prevent heart attacks and strokes. This medication belongs to a class of drugs known as monoclonal antibodies. It works by improving how well your body gets rid of LDL cholesterol. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. In 2023, this provider wrote 11 Medicare prescriptions for Repatha Sureclick, about a third of the volume of the typical Indiana prescriber of this medication (37). Medicare paid an average of $742.06 per fill, versus $872.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 14.6 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2023 | |||
| Humulin RInsulin Regular, Human | 11 | $688.52 | ▼ Less than typical |
About Humulin R: Inhaled insulin powder is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a short-acting insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This product is absorbed into the blood through your lungs. It starts working faster and lasts for a shorter time than regular insulin injected under the skin. It is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin). In 2023, this provider wrote 11 Medicare prescriptions for Humulin R, about 61% of the volume of the typical Indiana prescriber of this medication (18). Medicare paid an average of $688.52 per fill, versus $294.23 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17.4 30-Day Fills standardized to 30-day supplies 490 Days of Medication total across all patients in 2023 | |||
| Hydrocortisone | 11 | $117.68 | ▼ Less than typical |
About Hydrocortisone: Hydrocortisone is a man-made version of a natural substance (cortisol) made by the adrenal gland. Show more ▾ This drug is used to treat low cortisol levels caused by diseases of the adrenal gland (such as Addison's disease, adrenocortical insufficiency). Hydrocortisone belongs to a class of drugs known as corticosteroids. Corticosteroids are needed in many ways for the body to function well. They are important for salt and water balance and keeping blood pressure normal. The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. In 2023, this provider wrote 11 Medicare prescriptions for Hydrocortisone, about a third of the volume of the typical Indiana prescriber of this medication (30). Medicare paid an average of $117.68 per fill, versus $20.77 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for HASAN M QUTOB MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Endocrinology, Diabetes & Metabolism prescribing approach at this Michigan City, IN practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among IN prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.